Anhui Huaertai Chemical Co., Ltd. (SHE:001217)
China · Delayed Price · Currency is CNY 12.15
+0.19 (1.59%)
Apr 29, 2026, 1:15 PM CST
Anhui Huaertai Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,120 | 2,072 | 1,626 | 1,776 | 2,089 | 1,887 |
Other Revenue | - | - | 15.14 | 15.72 | 12.33 | 6.84 |
| 2,120 | 2,072 | 1,641 | 1,792 | 2,101 | 1,894 | |
Revenue Growth (YoY) | 23.47% | 26.24% | -8.42% | -14.73% | 10.97% | 65.02% |
Cost of Revenue | 2,005 | 2,072 | 1,428 | 1,507 | 1,755 | 1,289 |
Gross Profit | 114.82 | -0.29 | 213.37 | 284.95 | 346.64 | 605.06 |
Selling, General & Admin | 68.51 | - | 77.08 | 62.61 | 57.97 | 63.84 |
Research & Development | 71.46 | - | 49.6 | 55.5 | 64.48 | 60.25 |
Other Operating Expenses | -8.48 | - | -1.93 | -0.65 | 12.87 | 13.63 |
Operating Expenses | 131.49 | - | 124.49 | 116.92 | 135.09 | 139.03 |
Operating Income | -16.67 | -0.29 | 88.88 | 168.03 | 211.55 | 466.03 |
Interest Expense | -1.91 | - | -1.62 | -0 | - | -0.58 |
Interest & Investment Income | - | - | 4.45 | 19.04 | 17.49 | 2.08 |
Currency Exchange Gain (Loss) | - | - | 0.11 | 0.08 | -0.34 | 0.04 |
Other Non Operating Income (Expenses) | 5.16 | 6.29 | -0.36 | -0.5 | -0.85 | -0.17 |
EBT Excluding Unusual Items | -13.41 | 6 | 91.47 | 186.66 | 227.85 | 467.39 |
Gain (Loss) on Sale of Investments | -1.27 | - | 1.15 | -2.98 | 8.19 | 1 |
Gain (Loss) on Sale of Assets | - | - | - | 0.03 | -2.07 | - |
Asset Writedown | -12.64 | - | -0.63 | -6.57 | -0.86 | -0.89 |
Other Unusual Items | - | - | 7.38 | 4.3 | 19.49 | 14.49 |
Pretax Income | -27.33 | 6 | 99.37 | 181.43 | 252.59 | 482 |
Income Tax Expense | 33.74 | 35.44 | 11.63 | 23.16 | 32.83 | 66.41 |
Net Income | -61.06 | -29.44 | 87.74 | 158.28 | 219.77 | 415.59 |
Net Income to Common | -61.06 | -29.44 | 87.74 | 158.28 | 219.77 | 415.59 |
Net Income Growth | - | - | -44.56% | -27.98% | -47.12% | 147.45% |
Shares Outstanding (Basic) | 333 | 327 | 337 | 330 | 333 | 270 |
Shares Outstanding (Diluted) | 333 | 327 | 337 | 330 | 333 | 270 |
Shares Change (YoY) | -1.81% | -3.07% | 2.34% | -0.97% | 23.39% | 7.66% |
EPS (Basic) | -0.18 | -0.09 | 0.26 | 0.48 | 0.66 | 1.54 |
EPS (Diluted) | -0.18 | -0.09 | 0.26 | 0.48 | 0.66 | 1.54 |
EPS Growth | - | - | -45.83% | -27.27% | -57.14% | 129.85% |
Free Cash Flow | -135.65 | - | -146.97 | -344 | -107.05 | 256.93 |
Free Cash Flow Per Share | -0.41 | - | -0.44 | -1.04 | -0.32 | 0.95 |
Dividend Per Share | - | - | 0.100 | 0.100 | 0.100 | 0.300 |
Dividend Growth | - | - | - | - | -66.67% | - |
Gross Margin | 5.42% | -0.01% | 13.00% | 15.90% | 16.50% | 31.95% |
Operating Margin | -0.79% | -0.01% | 5.42% | 9.38% | 10.07% | 24.61% |
Profit Margin | -2.88% | -1.42% | 5.35% | 8.83% | 10.46% | 21.95% |
Free Cash Flow Margin | -6.40% | - | -8.96% | -19.20% | -5.09% | 13.57% |
EBITDA | 352.24 | 118.28 | 207.46 | 284.82 | 319.28 | 548.04 |
EBITDA Margin | 16.61% | 5.71% | 12.64% | 15.90% | 15.19% | 28.94% |
D&A For EBITDA | 368.9 | 118.57 | 118.57 | 116.79 | 107.73 | 82.01 |
EBIT | -16.67 | -0.29 | 88.88 | 168.03 | 211.55 | 466.03 |
EBIT Margin | -0.79% | -0.01% | 5.42% | 9.38% | 10.07% | 24.61% |
Effective Tax Rate | - | 590.88% | 11.71% | 12.76% | 13.00% | 13.78% |
Revenue as Reported | - | - | 1,641 | 1,792 | 2,101 | 1,894 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.